Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Endothelin antagonists for cerebral ischemia

Aug. 13, 1997

P&U antioxidant shows cerebroprotective activity in rats

Aug. 13, 1997

Elan licenses Morphelan to Targon Corporation

Aug. 13, 1997

Imminent launch of Novartis' Alzheimer's disease therapy

Aug. 12, 1997

Metabolic studies on sameridine described at ISSX meeting

Aug. 11, 1997

Metabolism of antidepressant studied in vivo

Aug. 11, 1997

Almotriptan metabolic pathway in humans described

Aug. 11, 1997

Mathematical model for predicting S-15535 metabolism in humans

Aug. 11, 1997

Lilly reports new agent for brain injury

Aug. 11, 1997

Tacrine analogs reported for Alzheimer's disease

Aug. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...